Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication

References

• Wang C, Pan R, Wan X, et al. A longitudinal study on the mental health of the general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020;87:40–48. PMID: 32298802; PMCID: PMC7153528. doi:10.1016/j.bbi.2020.04.028
   PubMed Web of Science ®Google Scholar
• Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes MetabSyndr. 2020;14(5):779–788. PMID: 32526627; PMCID: PMC7255207. doi:10.1016/j.dsx.2020.05.035
   Web of Science ®Google Scholar
• Castellini G, Rossi E, Cassioli E, et al. A longitudinal observation of general psychopathology before the COVID-19 outbreak and during lockdown in Italy. J Psychosom Res. 2021;141:110328. PMID: 33316632; PMCID: PMC7716728. doi:10.1016/j.jpsychores.2020.110328
   PubMed Web of Science ®Google Scholar
• Di Crosta A, Palumbo R, Marchetti D, et al. Individual differences, economic stability, and fear of contagion as risk factors for PTSD symptoms in the COVID-19 emergency. Front Psychol. 2020;11:567367. PMID: 33013604; PMCID: PMC7506146. doi:10.3389/fpsyg.2020.567367
   PubMed Web of Science ®Google Scholar
• Georgieva I, Lepping P, Bozev V, et al. Prevalence, new incidence, course, and risk factors of PTSD, depression, anxiety, and panic disorder during the covid-19 pandemic in 11 Countries. Healthcare. 2021;9(6):664. PMID: 34204925; PMCID: PMC8227861. doi:10.3390/healthcare9060664
   Web of Science ®Google Scholar
• Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55–64. PMID: 32799105; PMCID: PMC7413844. doi:10.1016/j.jad.2020.08.001
   PubMed Web of Science ®Google Scholar
• Liu CH, Zhang E, Wong GTF, Hyun S, Hahm HC. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: clinical implications for U.S. young adult mental health. Psychiatry Res. 2020;290:113172. PMID: 32512357; PMCID: PMC7263263. doi:10.1016/j.psychres.2020.113172
   PubMed Web of Science ®Google Scholar
• Li W, Zhang H, Zhang C, et al. The prevalence of psychological status during the COVID-19 epidemic in China: a systemic review and meta-analysis. Front Psychol. 2021;12:614964. PMID: 34017278; PMCID: PMC8129549. doi:10.3389/fpsyg.2021.614964
   PubMed Web of Science ®Google Scholar
• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–1699. PMID: 28413064. doi:10.1016/S0140-6736(17)30933-9
   PubMed Web of Science ®Google Scholar
• Buneviciene I, Bunevicius R, Bagdonas S, Bunevicius A. The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic. J Public Health. 2021:fdab248. PMID: 34179996. doi:10.1093/pubmed/fdab248
   Web of Science ®Google Scholar
• Thombs BD, Kwakkenbos L, Henry RS, et al. Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. J Psychosom Res. 2020;139:110262. PMID: 33070043; PMCID: PMC7532799. doi:10.1016/j.jpsychores.2020.110262
   PubMed Web of Science ®Google Scholar
• Wu Y, Kwakkenbos L, Henry RS, et al. Validation of the COVID-19 fears questionnaires for chronic medical conditions: a scleroderma patient-centered intervention network COVID-19 cohort study. J Psychosom Res. 2020;139:110271. PMID: 33096402; PMCID: PMC7543945. doi:10.1016/j.jpsychores.2020.110271
   PubMed Web of Science ®Google Scholar
• Wu Y, Kwakkenbos L, Henry RS, et al. Factors associated with fears due to COVID-19: a Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study. J Psychosom Res. 2021;140:110314. PMID: 33271402; PMCID: PMC7685938. doi:10.1016/j.jpsychores.2020.110314
   PubMed Web of Science ®Google Scholar
• Kavadichanda C, Shobha V, Ghosh P, et al. Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR). Rheumatol Adv Pract. 2021;5(2):rkab027. PMID: 34095747; PMCID: PMC8135468. doi:10.1093/rap/rkab027
   PubMedGoogle Scholar
• Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1(1):15002. PMID: 27189141. doi:10.1038/nrdp.2015.2
   PubMed Web of Science ®Google Scholar
• Rodpothong P, Auewarakul P. Viral evolution and transmission effectiveness. World J Virol. 2012;1(5):131–134. PMID: 24175217; PMCID: PMC3782273. doi:10.5501/wjv.v1.i5.131
   PubMedGoogle Scholar
• Available from: https://covid19.infn.it/sommario/rt.html. COVIDSTAT INFN - Istituto Nazionale di Fisica Nucleare. Accessed July 5, 2022.
   Google Scholar
• Sapra A, Bhandari P, Sharma S, Chanpura T, Lopp L. Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a primary care setting. Cureus. 2020;12(5):e8224. PMID: 32582485; PMCID: PMC7306644. doi:10.7759/cureus.8224
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang D, Xu D, et al. Loneliness, depression, anxiety, and post-traumatic stress disorder among Chinese adults during COVID-19: a cross-sectional online survey. PLoS One. 2021;16(10):e0259012. PMID: 34673812; PMCID: PMC8530321. doi:10.1371/journal.pone.0259012
   PubMed Web of Science ®Google Scholar
• Orlandi M, Lepri G, Damiani A, et al. One year in review 2020: systemic sclerosis. ClinExpRheumatol. 2020;38(3):3–17.
   Web of Science ®Google Scholar
• Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021;17(2):71–72. PMID: 33339986; PMCID: PMC7747184. doi:10.1038/s41584-020-00562-2
   PubMed Web of Science ®Google Scholar
• Ferri C, Giuggioli D, Raimondo V, et al. Covid-19 And rheumatic autoimmune systemic diseases: role of pre-existing lung involvement and ongoing treatments. Curr Pharm Des. 2021;27(41):4245–4252. PMID: 34477509. doi:10.2174/1381612827666210903103935
   PubMed Web of Science ®Google Scholar
• Avouac J, Airó P, Carlier N, Matucci-Cerinic M, Allanore Y. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020. doi:10.1136/annrheumdis-2020-217864
   Web of Science ®Google Scholar
• Mariano RZ, Del Rio APT, Reis F. COVID-19 overlapping with systemic sclerosis. Rev Soc Bras Med Trop. 2020;53:1–6. doi:10.1590/0037-8682-0450-202014
   Web of Science ®Google Scholar
• Orlandi M, Lepri G, Bruni C, et al. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol. 2020;39(7):2043–2047. PMID: 32514674; PMCID: PMC7276334. doi:10.1007/s10067-020-05193-2
   PubMed Web of Science ®Google Scholar
• Namdar P, Mojabi NA, Mojabi B. Neuropsychological and psychosocial consequences of the COVID-19 pandemic. Neurophysiology. 2021:1–10. PMID: 34400849; PMCID: PMC8357964. doi:10.1007/s11062-021-09903-7
   Web of Science ®Google Scholar
• Matucci-Cerinic M, Bruni C, Allanore Y, et al. Systemic sclerosis and the COVID-19 pandemic: world scleroderma foundation preliminary advice for patient management. Ann Rheum Dis. 2020;79(6):724–726. PMID: 32349982. doi:10.1136/annrheumdis-2020-217407
   PubMed Web of Science ®Google Scholar
• Hsieh YP, Yen CF, Wu CF, Wang PW. Nonattendance at scheduled appointments in outpatient clinics due to COVID-19 and related factors in Taiwan: a health belief model approach. Int J Environ Res Public Health. 2021;18(9):4445. PMID: 33922171; PMCID: PMC8122706. doi:10.3390/ijerph18094445
   PubMed Web of Science ®Google Scholar
• Thombs BD, Kwakkenbos L, Carrier ME, et al. Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. J Psychosom Res. 2020;135(110132). PMID: 32521358; PMCID: PMC7224675. doi:10.1016/j.jpsychores.2020.110132
   PubMed Web of Science ®Google Scholar
• Minniti A, Maglione W, Pignataro F, Cappadona C, Caporali R, Del Papa N. Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity. Clin Rheumatol. 2020;39(7):2063–2065. PMID: 32462423; PMCID: PMC7251048. doi:10.1007/s10067-020-05191-4
   PubMed Web of Science ®Google Scholar
• Pellegrino G, Mohammad Reza Beigi D, Angelelli C, et al. COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort. Clin Rheumatol. 2021;40(4):1393–1397. PMID: 33188620; PMCID: PMC7666573. doi:10.1007/s10067-020-05504-7
   PubMed Web of Science ®Google Scholar